Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jianji Xu"'
Publikováno v:
BMC Complementary and Alternative Medicine, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background MicroRNAs(miRNAs)are involved in the initiation and progression of hepatocellular carcinoma. ESC, an extract of Stellerachamaejasme L, had been confirmed as a potential anti-tumor extract of Traditional Chinese Medicine. In light
Externí odkaz:
https://doaj.org/article/206d4e31dc8d488ea7712bfaa6331a8b
Autor:
Jianji Xu1,2,3, Yunjin Zang1,4, Dongjie Liu1,2,3, Tongwang Yang1,2,3, Jieling Wang1,2,3, Yanjun Wang1,2,3, Xiaoni Liu1,2,3 lxnlxm@126.com, Dexi Chen1,2,3 dexichen@ccmu.edu.cn
Publikováno v:
Aging & Disease. Jan2018, Vol. 10 Issue 1, p82-93. 12p.
Publikováno v:
Journal of Nanoscience and Nanotechnology. 18:3865-3869
Nanoparticles were used as ideal carrier for its passive and active targeting property. Unfortunately, many of them were failed for its biotoxicology. Thus, find a safe and targeted drug delivery was the new goal of pharmaceutical industries. Here, A
Autor:
Jianji Xu, Xiaoxiao Yu, Xiaoni Liu, Boxin Kou, Dexi Chen, Mengyin Chai, Yunjin Zang, Shuang Wang
Publikováno v:
International Journal of Oncology. 51:1291-1299
The present study was designed to investigate the synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 (Aspp2-ad) and oxaliplatin via p53-independent pathway in vitro and in vivo. After being treated with
Publikováno v:
BMC Complementary and Alternative Medicine
BMC Complementary and Alternative Medicine, Vol 18, Iss 1, Pp 1-11 (2018)
BMC Complementary and Alternative Medicine, Vol 18, Iss 1, Pp 1-11 (2018)
Background MicroRNAs(miRNAs)are involved in the initiation and progression of hepatocellular carcinoma. ESC, an extract of Stellerachamaejasme L, had been confirmed as a potential anti-tumor extract of Traditional Chinese Medicine. In light of the im
Autor:
Tongwang Yang, Jieling Wang, Dexi Chen, Yanjun Wang, Jianji Xu, Dongjie Liu, Xiaoni Liu, Yunjin Zang
Publikováno v:
Aging and Disease
Liver hypoxia/ischemia injury leads to acute liver injury, delayed graft dysfunction, and failure during liver transplantation. Previous studies showed that autophagy is involved in liver hypoxia/ischemia injury. Our and others’ studies have found
Autor:
XIAONI LIU, JIANJI XU, SHUANG WANG, XIAOXIAO YU, BOXIN KOU, MENGYIN CHAI, YUNJIN ZANG, DEXI CHEN
Publikováno v:
International Journal of Oncology; Oct2017, Vol. 51 Issue 4, p1291-1299, 9p